Table 2 Interventional protocols reviewed by the WHO Ethics Review Committee
Intervention | Product | R&D Phase | Country | Protocol ID (design) |
|---|---|---|---|---|
Vaccine | VSVΔG-ZEBOV | Phase I/II | Switzerland | NCT02287480 |
Kenya | NCT02296983 | |||
Gabon | PACTR201411000919191 | |||
Germany | NCT02283099 | |||
Phase II | Guinea (survivors and their contacts and contacts of contacts) | No registration number available. | ||
Phase III | Guinea (general population) | PACTR201503001057193 | ||
Sierra Leone (general population) | Amendment of PACTR201503001057193 | |||
Guinea (healthcare workers) | Component of PACTR201503001057193 | |||
cAd3-EBOZ | Phase Ib | Mali | NCT002267109 | |
The Gambia | Not registered, Not initiated. | |||
Switzerland | NCT02289027 | |||
Treatment | Brincidofovir | Phase II | Liberia | NCT02271347 |
Favipiravir | Phase II | Guinea | NCT02329054 | |
MEURI | Guinea | N/A | ||
MIL 77 | MEURI | Sierra Leone, Guinea | N/A | |
Convalescent plasma | Phase II/III | Guinea | NCT02342171 |